Illusion Aligners is a clear-aligner manufacturing startup based in Mumbai, India, that makes orthodontic aligners for dentists and patients.

This Startup Deep Dive explains what Illusion Aligners does, how it makes money, who backs it, how it compares with rivals and what could go wrong, using publicly available information. It is educational and not investment advice. Last updated: October 2026.

Illusion Aligners in Brief

• What it is: Illusion Aligners is an Indian Clear aligner manufacturer company based in Mumbai.
• Who it serves: patients, doctors, hospitals, diagnostic centres, insurers and employers.
• Manufactures clear aligners in India under variants PRO, Aesthetic and FLX (company-stated).
• Sells through dentists and orthodontists; supported by 3D iModify treatment-planning software and the iScanPro intraoral scanner.
• First Indian brand to receive US FDA 510(k) clearance for clear aligners, in 2021 (reported).
• Funding: Parent Laxmi Dental IPO, January 2025: Rs 698 crore issue (Rs 138 crore fresh, Rs 560 crore offer for sale).

Illusion Aligners Quick Facts

Figures marked “reported” come from published reports and may differ between sources; “Not disclosed” means no reliable public figure was found.

What Is Illusion Aligners?

Illusion Aligners operates in the Clear aligner manufacturer space in India. Understanding a company like this starts with three questions: who is the customer, what painful problem is being solved, and why the solution is better than the alternatives. The sections below apply that lens to Illusion Aligners.

• Manufactures clear aligners in India under variants PRO, Aesthetic and FLX (company-stated).
• Sells through dentists and orthodontists; supported by 3D iModify treatment-planning software and the iScanPro intraoral scanner.
• First Indian brand to receive US FDA 510(k) clearance for clear aligners, in 2021 (reported).
• Kareena Kapoor is the brand ambassador.

The Origin Story of Illusion Aligners

Every company starts from a noticed gap and a team willing to commit to closing it. Strong origin stories are specific: a clear problem, a founding team with relevant skills, and an early product that real customers could test. Founder-market fit, meaning the team’s lived experience or technical depth in the domain, tends to predict how fast a young company learns.

• Founders: Rajesh Khakhar.
• Rajesh Khakhar (also spelled Khakkar) founded Illusion Dental Lab in 1989 as a small lab with a team of two.
• The lab grew to over 1,800 employees across the group by 2024.
• Sameer Merchant joined in 2001 and led the push into digital dentistry; he is CEO of Illusion Aligners.
• The aligner brand is part of listed Laxmi Dental Ltd, promoted by Rajesh Khakhar and Sameer Merchant.

Key Milestones and Challenges

No startup grows in a straight line. Early years usually involve slow adoption, product rewrites, hiring mistakes and funding gaps. In the Clear aligner manufacturer sector the common turning points are a first paying customer, a regulatory approval, a successful product demonstration or a funding round that lets the team invest ahead of demand. How a team responds to setbacks says more about resilience than any single headline.

• 1989: Illusion Dental Lab founded.
• 2021: Illusion Aligners receives US FDA 510(k) clearance.
• February 15, 2024: Record aligner 1900 mm by 1650 mm made from Taglus PETG (another report gives a different size).
• April 19, 2024: India Book of Records certificate presented.
• January 2025: Parent Laxmi Dental IPO, listed 20 January 2025 on BSE and NSE.

Illusion Aligners Funding and Investors

Funding history shows how much outside confidence a company has attracted and how long it can operate before needing more capital. Figures below are reported and may differ between sources; valuation figures are estimates unless the company has confirmed them.

• January 2025: Laxmi Dental IPO of Rs 698 crore (Rs 138 crore fresh issue, Rs 560 crore offer for sale); anchor investors put in about Rs 314 crore.
• Fresh-issue money is for debt repayment, capex and subsidiary Bizdent Devices.

How Does Illusion Aligners Make Money? (Business Model)

A business model describes who pays, how often and how much it costs to serve them. Strong models show repeat usage, improving margins with scale and acquisition channels that do not depend only on paid spend. Weak models show one-off sales, rising costs and growth that stops when spending stops. For companies selling to patients, doctors, hospitals, diagnostic centres, insurers and employers, sales cycles and contract size matter as much as headline growth.

• Makes and sells aligners via an eight-step process from impression collection to packing (company-stated).
• Parent earns from dental labs, aligners, exports and paediatric products; aligners were about 31% of parent revenue in H1 FY25, up from about 17.5% in FY22.

The Numbers: Illusion Aligners Financials

Financial figures show whether growth is turning into a self-sustaining business. Small and private companies often disclose little, so any number below is included only if it was found in public reporting.

• Parent Laxmi Dental: FY23 revenue about Rs 162 crore with a loss of about Rs 4 crore; FY24 revenue about Rs 194-195 crore (reports differ slightly) with profit of about Rs 25 crore; H1 FY25 revenue about Rs 118 crore.
• Exports were about 32.5% of parent revenue in FY24.
• Brand-level (Illusion Aligners) revenue is not separately disclosed.

Market Opportunity for Illusion Aligners

Market size is easy to exaggerate, so a useful approach separates the total market from the portion a company can realistically reach with its current product and distribution. The main forces behind demand in this sector are rising chronic disease, growing health insurance penetration, government programmes such as Ayushman Bharat and the Ayushman Bharat Digital Mission, and the shift of care to digital and home settings. Each of these widens the opportunity, but capital efficiency and execution decide who captures it.

• India's clear aligner market is growing, with premium Invisalign at Rs 1.5-3.5 lakh and domestic brands far cheaper.
• Illusion positions as a domestic manufacturer supplying dentists.

Technology and Product at Illusion Aligners

Technology is rarely the whole moat, but it drives speed, cost and customer experience. A practical way to assess it is to separate the capability the company controls from the commodity infrastructure it rents. In this sector the important factors are clinical validity, data quality, integration with hospital and lab systems, and trust among doctors and patients.

• US FDA 510(k) clearance claim for aligners; digital planning software and intraoral scanner.
• Aligners thermoformed from PETG sheet with laser marking and polishing (company-stated).

Team and Culture at Illusion Aligners

Teams are the most important and least measurable asset of a young company. Look at how complementary the founders’ skills are, how deep the second layer of leadership is, and how the company hires and retains specialists. Culture shows up in small repeated behaviours: how quickly bad news travels upward and whether commitments to customers are kept.

• Sameer Merchant is CEO and Mitesh Kariya is COO of Illusion Aligners.
• Rajesh Khakhar is founder.

Illusion Aligners Competitors: Competitive Landscape

A fair competitive analysis names direct rivals, adjacent players who could move into the space, and the customer’s default alternative. Durable advantages include proprietary data or technology, licences and approvals, brand trust, switching costs and cost leadership.

Risks and Challenges for Illusion Aligners

• Parent reported losses in FY22 and FY23 and a FEMA non-compliance flag in the FY24 audit.
• 98.6% of parent production is in Mumbai; high employee attrition (27% in FY23).
• FDA and record claims are company-stated; promoter litigation noted in IPO risk factors.
• Regulatory risk: medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules.
• Clinical and liability risk: errors in care, diagnosis or product quality can damage trust quickly.

Risk is not a reason to avoid a company; it is a reason to price it correctly and to monitor the right indicators over time. Regulation in this sector is shaped by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Illusion Aligners Growth Outlook: What to Watch

• Aligners are the parent's fastest-growing segment; IPO funds earmarked for debt repayment and capex.
• No brand-specific targets found.
• Key indicators: patient or user volumes, repeat usage, gross margin, clinical outcomes and cost of acquiring each customer.
• Funding position: Whether Illusion Aligners can reach its next milestone before needing new capital.
• Regulation: Changes from the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act.

Industry Context: Where Illusion Aligners Fits

India's healthcare market combines a large public system, a fast-growing private hospital sector and an increasingly digital layer. Government initiatives such as Ayushman Bharat and the Ayushman Bharat Digital Mission aim to widen insurance cover and create common digital health records, while telemedicine guidelines and the Digital Personal Data Protection Act shape how digital care and patient data can be used.

Demand is driven by chronic and lifestyle disease, an ageing population, rising insurance penetration and consumers who now expect to book, pay and consult online. Startups in this field compete on trust, clinical quality and convenience, and they must prove outcomes and safety as well as growth.

For readers new to this field, a useful habit is to separate announcements from evidence. A plan, a partnership or a funding headline describes intent, while a delivered product, a paying customer or an audited financial statement describes results. Comparing the two over time shows how reliably a company turns promises into outcomes.

Bull Case and Bear Case for Illusion Aligners

An investment thesis is a short, testable statement of why a company could become far more valuable, together with what evidence would prove it wrong. The points below are general to this sector and are not forecasts for Illusion Aligners.

Bull case

• Rising insurance cover and digital adoption expand the customer base.
• Strong clinical evidence builds trust with doctors and hospitals.
• Scale can improve unit economics in diagnostics and care delivery.

Bear case

• Regulatory changes can alter permitted products or business models.
• Customer acquisition costs can erode margins.
• A single safety or privacy incident can damage trust.

Lessons Founders and Investors Can Take from Illusion Aligners

Studying a company in the Clear aligner manufacturer space offers lessons that go beyond any single firm. The points below are general lessons for the sector and are not claims about Illusion Aligners.

• Trust is the real currency in healthcare, so quality control, clinical evidence and data protection must be built in from the start.
• Distribution through hospitals, clinics, insurers or employers can matter more than a standalone consumer app.
• Unit economics improve when repeat usage replaces expensive one-time customer acquisition.
• Regulatory approvals can take time, so timelines and cash planning should allow for them.
• Integration with existing hospital, lab and records systems reduces friction for adoption.

How to Evaluate Illusion Aligners as a Startup

• Customer clarity: Can Illusion Aligners name its customer and the problem it solves in one sentence?
• Evidence of demand: Look for repeat customers, signed contracts or measurable usage rather than announcements alone.
• Economics: Check whether margins improve as volume grows.
• Execution: Compare announced timelines with what has actually been delivered.
• Funding runway: Estimate how long current capital lasts at the present spending rate.
• Regulatory standing: Confirm required approvals are in place.
• Customer concentration: Check whether a few customers account for most of the revenue.
• Management depth: Look for experienced leaders beyond the founders and a stable core team.

The Takeaway

Illusion Aligners is part of India’s growing Clear aligner manufacturer ecosystem. The useful lesson from studying it is the discipline of asking structured questions about customers, economics, advantage and resilience. Companies that answer them well, repeatedly and under pressure are the ones that endure. Readers should treat any single report, ranking or funding headline as one input among many, and should re-check key facts against recent company announcements. Because public information on young companies is often limited, patience in verifying claims is part of good analysis. This article is educational and is not investment advice.

• Clear customers and repeat demand matter more than announcements.
• Regulation and capital needs shape how fast a startup in this sector can grow.
• Track a few leading indicators over time rather than one headline metric.

Illusion Aligners FAQs: Frequently Asked Questions

What is Illusion Aligners?

Illusion Aligners is a clear-aligner manufacturing startup based in Mumbai, India, that makes orthodontic aligners for dentists and patients. It is profiled in the Startup Deep Dive series, which explains business model, funding, competitors and risks.

Who founded Illusion Aligners?

Illusion Aligners was founded by Rajesh Khakhar, and the company reports a founding year of 1989 (parent Illusion Dental Lab); aligner brand launched later.

How much funding has Illusion Aligners raised?

Parent Laxmi Dental IPO, January 2025: Rs 698 crore issue (Rs 138 crore fresh, Rs 560 crore offer for sale). Funding figures are reported and may differ between sources, so readers should check the latest company announcements.

How does Illusion Aligners make money?

Illusion Aligners earns revenue from its Clear aligner manufacturer products and services sold to patients, doctors, hospitals, diagnostic centres, insurers and employers. The exact revenue mix is described in the business model section and is not fully disclosed publicly.

Who are the competitors of Illusion Aligners?

Reported rivals include Invisalign (Align Technology), Toothsi, TeethLogic, Snazzyalign, LoveMyBraces, 32 Watts and Rejove Aligners. See the competitor comparison above for how they differ.

What are the main risks for Illusion Aligners?

Main risks include medical devices, diagnostics, online pharmacy and telemedicine each face different and changing rules, funding and capital needs, competition and regulation by the CDSCO, state health regulators, the National Medical Commission and the Digital Personal Data Protection Act. This is educational content, not investment advice.

Related Startup Deep Dives: Clove Dental — Clove Dental: 500+ owned clinics and about $116M raised | Milaap — short profile of what is publicly known. Browse the full Startup Deep Dive series.

Source

Source: Publicly available data, published reports, industry research, and other credible sources.